key: cord-0790255-2qasg3gw
authors: van Leeuwen, Dirk J.
title: Ethical and Legal Aspects of Pandemics During COVID‐19 and Beyond for the Hepatology Community
date: 2021-07-22
journal: Clin Liver Dis (Hoboken)
DOI: 10.1002/cld.1124
sha: 21d4bb4e627941ecf10d56aae3c72db912813045
doc_id: 790255
cord_uid: 2qasg3gw

nan

Implementing new concepts and policies in clinical hepatology during and after the coronavirus disease 2019 (COVID-19) pandemic requires awareness of ethical and legal issues. Prior pandemics highlight common events that can help guide preparedness for the future. 1, 2 Descriptions of prior health catastrophes, such as the bubonic plague, include exhausted health care workers, inability to keep up with the dead, government restrictions, medical professionals under scrutiny, firing of those who brought bad news, overreach by governments, censorship, public anger, and violence. They illustrate the challenges to translate medical advice into workable policies. In 2007, 194 countries, including the United States, signed updated binding international law and with a leading World Health Organization (WHO) role "to prevent, protect, control and provide a public review health response to the international spread of disease and which avoids unnecessary interference with international traffic and trade." 3 Extensive federal law is applicable in disaster/emergency situations. US states and governors have increasingly uniform regulations in place, in part enacted after 9/11 and the anthrax attacks. 4 ,5 Yet without coordinated national direction, little was uniform across states during the COVID-19 outbreak. The literature on ethical and legal implications surrounding the COVID-19 pandemic is rapidly evolving and accessible on multiple websites (Centers for Disease Control and Prevention, WHO, Bioethics.net, etc.). The COVID-19 pandemic has highlighted and enlarged the socioeconomic divide between the poor and the wealthy. 6, 7 eTHiCal anD leGal FraMewOrK DUrinG a PanDeMiC A comprehensive multidisciplinary input may be required with leadership shared with civil and/or military disaster authorities and community leaders 2, 8 (Fig. 1 ). Ethical and legal standards need to be refocused from the individual toward the best outcome for all (Fig. 2 ).

Any restrictions imposed may provoke strong opposition in society and should be limited to the minimum to accomplish a specific goal. Transparency is critically important and should include the scientific basis of guidelines and modifiers, such as shortages of resources, and with updates on the evolving role of testing, vaccines, and treatments. 8, 9 One-voice communication is key in attaining 

During times of scarcity of resources, medical selection criteria may be proposed for the best outcomes for most (Fig. 4 ). In the most severe scarcity situation, overwhelmed systems demand nonmedical choices (1 intensive care unit [ICU] bed for 10 acutely needy patients). Choices not only apply to patients with COVID-19 but to all who need and are entitled to intensive care, and dilemmas are challenging ( Fig. 5 and 6 ). 11, 12 As an example, Dutch ethicists, incorporating societal input of many groups, suggested resource allocation could be determined by factors such as the frailty index (beware of discrimination of handicapped people), selected health care workers with patient exposure if they had lacked access to protective devices, anticipated ICU turnaround time (short is preferred), or if all fails a lottery or first come, first saved. 13 "Life innings opportunities" refers to a concept that all people should have fair and equal chances to complete various stages of life. 14 People can be divided into generational groups of ages, such as <40, 40 to 60, 60 to 80, and >80 years and somewhat less restrictive as specific age per se. Noteworthy, older people showed a considerable willingness to give up their spot for a younger person. Is predicted remaining years to live easier and also fair? Typical questions may come up, for example, if a 23-year-old "drunk driver" carpenter is more deserving than a 68-year-old hepatologist. However, personal faults/guilt tends not to be used as an ethical exclusion criterion.

Against this background, what is the best time to communicate and prepare emotionally charged issues (updated living wills?) that cause anxiety to many elderly and high-risk patients? Again in the Netherlands, many older patients died at home after their primary care physicians guided them, before turning ill, in review of their options in case they were to contract COVID-19. Many (>50%) firmly decided that they did not want hospitalizations and weeks of ICU on their belly with uncertain rehabilitation perspectives. 13 How and which data will we present to the individual and our referring providers in the community for patients with likely a prolonged recovery period and a worsened clinical frailty score? 15 Social isolation with absence of farewell or funeral adds major grief that will have a health impact for years to come for survivors. The way potential outcomes are framed may clearly impact a patient's decisions. Will timely preparation of our patients reduce the decisive burden on care teams if new waves or comparable challenges would present?

In response to the pandemic, featured information on the American Association for the Study of Liver Diseases (AASLD) and other professional websites now includes safety aspects, telemedicine and billing, confidentiality issues, dilemmas surrounding procedures, and disease group-specific information. Yet applying this information across the COVID-19 patient spectrum is challenging. Patients with chronic liver disease (CLD) with COVID-19 are heterogeneous, from those with abnormal liver tests identified incidentally on routine bloodwork to patients with end-stage liver disease. Patients with CLD at risk for poor outcomes from COVID-19 infection also need to balance the risk for exposure to health consequences of missing surveillance testing and treatment of advanced liver disease, tumor, and/or liver transplantation.

Fortunately, we have already increasingly been acknowledging the role of palliative care when considering life-prolonging interventions. Now we have also to face the challenge of incorporating life expectancy and transplant opportunities into a COVID-19 medical and nonmedical triage system. We may need to forego transfer to an ICU in agreement with more general admission policies as recently proposed, and specifically in the case of multiorgan failure. 16 A call to action to address social determinants exposed by the COVID-19 pandemic was recently published in Hepatology. 17 The authors summarize the health care inequities in the United States and the impact of social conditions on individual health, especially disparities in liver disease prevalence, outcome, and access to care. This call to action is a natural extension of the ethical and legal considerations as a moral imperative to promote fairness, equitable access to care, compassion, and justice. Where individual and small group practices are increasingly becoming part of larger systems, the opportunities to share responsibility among all should increase considerably with multidisciplinary input, including home health care, palliative care, and social work. 

The history of pandemics gives us insights into the nature of problems to be expected and opportunities to address them. The 2021 challenges are how hepatology could translate a disaster era into an advantage, embedded in ethical and legal principles as outlined (Fig. 6) . A focus on disparities to equitable and fair access for all is a starting point that should also enhance value-based, costeffectiveness of care. It is encouraging that such topics are rapidly going to the list of priorities of the AASLD and our related hepatology and gastroenterology societies. This is a unique time to take a step back and review what we should do today and how we can shape a new future for hepatology that truly serves and inspires all.

Geisel School of Medicine, c/o Section of Gastroenterology and Hepatology

Pandemics and the shape of human history. The New Yorker

Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary

The new International Health Regulations: a revolutionary change in global health security

The Model State Emergency Health Powers Act: planning for and response to bioterrorism and naturally occurring infectious diseases

Ethical guidance for disaster response, specifically around crisis standards of care: a systematic review

COVID-19: global health equity in pandemic response

Food insecurity and COVID-19: disparities in early effects for US adults

Military medical ethics-physician first, last, always

Transparency during public health emergencies: from rhetoric to reality

Seattle's leaders let scientists take the lead

Triage decisions in the context of COVID-19: old burden, new challenge-the Structured Approach for Intensive Care Unit Triage (SAINT) Protocol

COVID-19 pandemic: triage for intensive-care treatment under resource scarcity (3rd, updated version)

Ethical advice for an intensive care triage protocol in the COVID-19 pandemic: lessons learned from The Netherlands

The fair innings argument and increasing life spans

The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study

Managing ICU surge during the COVID-19 crisis: rapid guidelines

Addressing social determinants of liver disease during the COVID-19 pandemic and beyond: a call to action